Method for the catalytic production of hydrocodone and hydromorphone

ABSTRACT

A method for the catalytic conversion of codeine, morphine or analogs thereof into hydrocodone, hydromorphone or analogs thereof utilizing a transition metal complex of a tertiary phosphine halide as catalyst.

CROSS REFERENCE TO RELATED APPLICATIONS

This application is a continuation of provisional application 60/425,360 filed Nov. 11, 2002.

FIELD OF THE INVENTION

The present invention relates to a method for the catalytic production of hydrocodone, hydromorphone, and analogs thereof, and more particularly to a method for catalytically converting codeine and morphine into hydrocodone and hydromorphone, respectively.

BACKGROUND OF THE INVENTION

Hydrocodone and hydromorphone are opioid analgesics having similar qualities to codeine and morphine. Conventional methods for producing hydrocodone and hydromorphone typically involve a two step oxidation/reduction route from codeine and morphine. Unfortunately, these methods are expensive and inefficient. Attempts to improve efficiency have included the use of catalytic methods. Known methods include the use of metallics, typically Ru, Rh, Pd and Pt on activated carbon as well as metallic complexes. The preparation of these catalysts is difficult, yields are poor, and isolation of the product is often burdensome.

Other catalytic methods, including the use of finely-divided platinum or palladium in an acidic media, are environmentally undesirable. Enzymatic methods of conversion have also been attempted, but as with the methods of catalysis discussed above, these methods are costly and difficult to scale up.

There is therefor a need for an improved method of conversion that is easily scaled up and economical for manufacturing purposes.

SUMMARY OF THE INVENTION

An aspect of the present invention is to provide a method for the catalytic conversion of a compound of Formula I into a compound of Formula II utilizing at least one transition metal complex of a tertiary phosphine halide as catalyst,

wherein R¹ is H, alkyl, aryl or acyl.

Another aspect of the present invention is to provide a one step method for the conversion of codeine or morphine into hydrocodone or hydromorphone, respectively.

These are merely illustrative aspects of the present invention and should not be deemed an all-inclusive listing of the innumerable aspects associated with the present invention. These and other aspects will become apparent to those skilled in the art in light of the following disclosure.

DETAILED DESCRIPTION

There is provided a method for the conversion of a compound according to Formula I to a compound according to Formula II,

wherein R¹ is H, alkyl, aryl or acyl.

The method of the present invention is especially useful where R¹ is methyl or H, i.e., codeine or morphine, respectfully, leading to the formation of hydrocodone or hydromorphone, respectfully.

The transition metal catalysts of the present invention comprise a transition metal complex of a tertiary phosphine halide, [M(PR² ₃)_(n)X_(m)]_(p), wherein M is preferably a Group VIII transition metal, R² is an alkyl or aryl, X is a halide or halide compound, n is 1, 2, 3 or 4, and m is 1 or 2. These complexes are capable of polymerizing, therefore p is at least 1. Preferred metals include Rh, Ru, Pd and Pt. The halide, X, is typically Cl or Br. Halide compounds include but are not limited to BF₄, PF₆, ClO₄, CF₃SO₃ and OCOCF₃. R² is an alkyl or aryl group, with phenyl being preferred. Many of these catalysts are commercially available, or are easily prepared as is known in the art.

In the above Formula I and Formula II alkyl groups useful therein include those having from about 1 to about 10 carbon atoms. Aryl groups in Formula I and Formula II include phenyl and substituted phenyl groups.

In one embodiment of the present invention the transition metal is Rh, and the metal complex is of the formula [Rh(PR² ₃)_(n)X]_(p), wherein R² is an alkyl or aryl, X is a halide, n is 1, 2 or 3, and p is at least 1, or of the formula [Rh(PR² ₃)_(n)Y]_(p), wherein R² is an alkyl or aryl, n is 1, 2 or 3, p is at least 1 and Y is a halide compound, preferably including BF₄, PF₆, ClO₄ or OCOCF₃.

In another embodiment the transition metal is Ru and the metal complex is of the formula [RuX₂(PR² ₃)_(n)]_(p) wherein R² is an alkyl or aryl, X is a halide, n is 1, 2, 3 or 4; and p is at least 1 or of the formula [RuYX(PR₃ ²)_(n)]_(p) wherein R² is an alkyl or aryl and wherein n=3, p is at least 1, Y═H and X═Cl; n=3, Y═H and X═H; n=4, X═H, Y═H; or n=2, 3 or 4, p is at least 1 and X═Y=ClO₄, CF₃SO₃H, PF₆ or BF₄.

A suitable method for producing a Ru complex of the present invention involves refluxing a Ru salt, for example RuCl₃xH₂O with an excess of triphenylphosphine in alcohol to form the complex [Ru(P(C₆H₅)₃)₃Cl₂]_(p).

A Rh complex of the present invention is also commercially available, or can be prepared by refluxing rhodium trichloride with triphenylphosphine in alcohol, typically methanol or ethanol.

The catalytic conversion of the present invention has the further economic advantage of being able to convert a salt of codeine or morphine, for example codeine hydrochloride or morphine hydrochloride, to hydrocodone or hydromorphone, respectively.

The reaction of the present invention may be accomplished by any conventional process. A suitable process includes dissolving the reactant of Formula I in a suitable solvent in a reaction vessel. Suitable solvents include but are not limited to alcohols, preferably primary and secondary lower alkyl alcohols. The reaction vessel is then flushed with an inert atmosphere, typically nitrogen. The catalyst is added and the reaction mixture is refluxed under the inert atmosphere until the conversion is essentially complete, typically at least about an hour. The reaction mixture is cooled and crystals of the product are collected. The product may be purified by recrystallization in a suitable solvent as is well known in the art, or by any other suitable conventional method of purification.

In an alternative embodiment a tertiary amine, for example triethylamine, is added to the reaction mixture when the preferred Ru complex catalyst is used. The tertiary amine reduces the formation of side products, primarily the alkaloid neopine, a potential side product in reactions of the present invention utilizing the preferred Ru catalyst.

In another alternative embodiment the alkaloid compound is added to the reactants that form the catalyst and the catalyst formation reaction takes place in the presence of the alkaloid. The ability to form the catalyst and subsequently accomplish the catalytic conversion in the same reaction vessel further enhances the economy of the reaction.

EXAMPLES Example 1

Codeine, 50.00 g, was dissolved in 200 ml methanol in a three-neck flask at room temperature. The flask was equipped with a condenser and nitrogen. The flask was flushed with nitrogen for five minutes with one neck opened. The catalyst, 0.50 g of RhCl(P(C₆H₅)₃)₃ was added to the solution. The flask was then flushed with nitrogen for another five minutes, and the open neck was closed. The reaction mixture was stirred under nitrogen and heated to reflux for four hours, then cooled to 0° C. for 30 minutes. The resulting crystals were removed by filtration. The collected crystals were washed four times with 10 ml cold methanol (5° C.), and dried in air for one hour yielding pale yellow crystals (41.50 g, yield 83%). The filtrate was pumped down to dryness to give 6.14 g yellow solid. The solid residue was dissolved in 40 ml refluxing methanol and cooled to 0° C. for 30 minutes and filtered. The collected crystals were washed four times with 3 ml portions of cold methanol (5° C.) and air dried for 2 hours yielding 3.41 g (6.8%) white crystals. HPLC analysis and NMR spectra confirm that the product is pure hydrocodone.

Example 2

Morphine, 50.00 g, was suspended in 500 ml methanol in a three neck flask equipped with condenser and nitrogen input and outlet. After refluxing under nitrogen for five minutes, one neck of the flask was opened. A catalyst, 0.50 g RhCl(P(C₆H₅)₃)₃ was added to the container. The opened neck was closed with a stopper. The reaction mixture was stirred under nitrogen and heated to reflux for 6 hours, cooled down to 0° C. for 30 minutes, and filtered. The collected solid was washed four times with cold methanol (5° C.) and dried in air for 20 minutes. The solid was kept under vacuum (15 mm Hg) at room temperature for 1 hour, yielding a white powder (38.83 g, yield 77.7%). The filtrate was distilled under nitrogen until only 200 ml of solution remained. It was cooled down to 0° C. for 30 minutes and filtered, yielding a white powder. The product was washed twice with 20 ml each and then once with 10 ml of cold methanol (5° C.) dried in air for 40 minutes to yield 3.48 g of a white powder product. HPLC analysis and NMR spectra confirm product is pure hydromorphone.

Example 3

Ruthenium dimer was prepared by refluxing 1 g RuCl₃xH₂O with 3 equivalents P(C₆H₅)₃ in EtOH (100 ml) overnight. The resulting catalyst, [Ru(P(C₆H₅)₃)₂Cl₂]₂ was obtained as a black precipitate after filtration, 63% yield.

Example 4

The catalyst of Example 3 was reacted with codeine in MeOH in the presence of triethylamine in the ratios shown in the table below. The reaction mixtures were flushed with N₂ for 5 minutes, heated to reflux under N₂, cooled to 0° C. and filtered. The recovered crystals were washed twice with 5 ml MeOH and air dried to yield white crystals.

TABLE 1 Hydrocodone/codeine/neopine Starting Materials [Ru(P(C₆H₅)₃)₂Cl₂]₂ MeOH NEt₃ Reaction time Products (area % by HPLC) Codeine 1.0 g 10 mg  5 ml  0.25 ml 2 h 0.85 g 96.7/1.8/0.33 Codeine 1.0 g 10 mg  5 ml  0.25 ml 3 h 0.99 g 94.7/0/0 Codeine 2.5 g 25 mg 12.5 ml   0.725 ml 3 h 1.58 g 100/0/0 Codeine 1 g/ 10 mg  5 ml  0.25 ml 3 h 0.61 g 97.4/1.0/0 Codeine. sulfate 0.05 g Codeine 1 g/ 55 mg 10 ml 0 3 h 1.17 g 77.5/2.5/0.8 CodeineHCL 0.05 g CodeineHCl 1.1 g 100 mg  10 ml 0 15 h  1.16 g 81.5/11.6/0 Morphine (recry) 1.0 g 80 mg 10 ml 0.25   3 days 1.08 g Hydromorphone/morphine = 88.6/6.1

Example 5

Codeine, 5.0 g, and 0.117 g catalyst, Ru(P(C₆H₅)₃)₃Cl₂, were dissolved in 25 ml EtOH. The mixture was flushed with nitrogen for 5 minutes. After refluxing under nitrogen for 2 hours the reaction mixture was cooled down to 0° C. and filtered. The collected crystals were washed twice with 5 ml each MeOH and dried in air for 1 hour to yield white crystals, 70% yield hydrocodone.

Example 6

Morphine, 1.0 g, and 80 mg [Ru(P(C₆H₅)₃)₂Cl₂]₂ was suspended in 10 ml MeOH. The reaction mixture was flushed with N₂ for 3 minutes, after which 0.25 ml triethylamine was added, and the mixture flushed with N₂ for another 3 minutes. The reaction mixture was heated to reflux with stirring under N₂ for 72 hours. The resulting solid was found to be hydromorphone.

Example 7

Codeine, 5.09 g, 25.4 mg RuCl₃xH₂O and 95.9 mg P(C₆H₅)₃ were added to 25 ml ethanol in a three neck flask. The flask was flushed with N₂ for 5 minutes. The mixture was heated until reactants dissolved, and then refluxed, under nitrogen, overnight. The resulting solution was washed twice with 5 ml each MeOH and air dried to yield 3.31 g product. Analysis determined the presence of hydrocodone and Ru catalyst.

Example 8

Codeine-HCl, 1.1 g and 0.1 g RuCl₂(P(C₆H₅)₃)₃ were stirred in 10 ml MeOH and flushed with N₂ for 5 minutes. The reaction mixture was refluxed overnight under N₂, cooled to room temperature and dried under vacuum, yielding 1.16 g brown solid containing hydrocodone.

From the foregoing description those skilled in the art will appreciate that economical and efficient methods for the catalytic conversion of codeine or morphine into hydrocodone or hydromorphone, respectively, are provided.

Having described the invention in detail, those skilled in the art will appreciate that modifications may be made of the invention without departing from its spirit and scope. Therefore, it is not intended that the scope of the invention be limited to the specific embodiments described. Rather, it is intended that the appended claims and their equivalents determine the scope of the invention. 

1. A method comprising catalytically converting a compound of Formula I into a compound of Formula II utilizing at least one transition metal complex of a tertiary phosphine halide, wherein R¹ is H, alkyl, aryl or acyl and wherein the metal complex is of the formula [M(PR² ₃)_(n)X_(m)]_(p) wherein M is a Group VIII transition metal, R² is an alkyl or aryl, X is H, a halide or halide compound, n is 1, 2, 3 or 4, p is at least 1 and m is 1 or 2


2. The method according to claim 1 wherein R¹ is H or CH₃.
 3. The method of claim 1 wherein the metal complex is of the formula [Rh(PR² ₃)_(n)X]_(p), wherein R² is an alkyl or aryl, X is a halide or halide compound, n is 1, 2 or 3 and p is at least
 1. 4. The method of claim 1 wherein the metal complex having the formula [Rh(PR² ₃)_(n)Y]_(p), wherein n is 1, 2 or 3, p is at least 1 and Y is selected from the group consisting of BF₄, PF₆, ClO₄ and OCOCF₃.
 5. The method of claim 1 wherein in the metal complex is of the formula [RuX₂(PR² ₃)_(n)]_(p) wherein R² is an alkyl or aryl, X is a halide, n is 1, 2, 3 or 4 and p is at least
 1. 6. The method of claim 1 wherein the metal complex is of the formula [RuYX(PR² ₃)_(n)]_(p) wherein R² is an alkyl or aryl and wherein n=3, p is at least 1, Y═H and X═Cl; or n=3, p is at least 1, Y═H and X═H; or n=4, p is at least 1, X═H, Y═H; or n=2, 3 or 4 and X═Y is selected from the group consisting of ClO₄, CF₃SO₃, PF₆ and BF₄.
 7. A method for producing hydrocodone comprising converting codeine into hydrocodone in the presence of at least one transition metal complex of a tertiary phosphine halide wherein the metal complex is of the formula [M(PR² ₃)_(n)X_(m)]_(p) wherein M is a Group VIII-transition metal, R² is an alkyl or aryl, X is H, a halide or halide compound, n is 1, 2, 3 or 4, p is at least 1 and m is 1 or
 2. 8. The method of claim 7 wherein the metal complex is of the formula [Rh(PR² ₃)_(n)X]_(p), wherein R² is an alkyl or aryl, X is a halide or halide compound, n is 1, 2 or 3 and p is at least
 1. 9. The method of claim 7 wherein the metal complex is of the formula [Rh(PR² ₃)_(n)Y]_(p), wherein R² is an alkyl or aryl, n is 1, 2 or 3, p is at least 1 and Y is selected from the group consisting of BF₄, PF₆, ClO₄ and OCOCF₃.
 10. The method of claim 7 wherein in the metal complex is of the formula [RuX₂(PR² ₃)_(n)]_(p) wherein R² is an alkyl or aryl, X is a halide, n is 1, 2, 3 or 4 and p is at least
 1. 11. The method of claim 7 wherein the metal complex is of the formula [RuYX(PR² ₃)_(n)]_(p) wherein R² is an alkyl or aryl and wherein n=3, p is at least 1, Y═H and X═Cl; or n=3, p is at least 1, Y═H and X═H; or n=4, X═H, Y═H; or n=2, 3 or 4, p is at least 1 and X═Y is selected from the group consisting of ClO₄, CF₃SO₃, PF₆ and BF₄.
 12. A method for producing hydrocodone comprising converting codeine into hydrocodone in the presence of at least one catalyst, wherein the catalyst includes RhCl(P(C₆H₅)₃)₃ or [Ru(P(C₆H₅)₃)₂Cl₂]₂.
 13. A method for producing hydromorphone comprising converting morphine into hydromorphone in the presence of at least one transition metal complex of a tertiary phosphine halide_wherein the metal complex is of the formula [M(PR² ₃)_(n)X_(m)]_(p) wherein M is a Group VIII -transition metal, R² is an alkyl or aryl, X is a halide or halide compound, n is 1, 2, 3 or 4, p is at least 1 and m is 1 or
 2. 14. The method of claim 13 wherein the metal complex is of the formula [Rh(PR² ₃)_(n)X]_(p), wherein R² is an alkyl or aryl, X is a halide or halide compound, n is 1, 2 or 3 and p is at least
 1. 15. The method of claim 13 wherein the metal complex is of the formula [Rh(PR² ₃)_(n)Y]_(p), wherein R² is an alkyl or aryl, n is 1, 2 or 3, p is at least 1 and Y is selected from the group consisting of BF₄, PF₆, ClO₄ and OCOCF₃.
 16. The method of claim 13 wherein in the metal complex is of the formula [RuX₂(PR² ₃)_(n)]_(p) wherein R² is an alkyl or aryl, X is a halide, n is 1, 2, 3 or 4 and p is at least
 1. 17. The method of claim 13 wherein the metal complex is of the formula [RuYX(PR² ₃)_(n)]_(p) wherein R² is an alkyl or aryl and wherein n=3, Y═H and X═Cl; or n=3, Y═H, p is at least 1 and X═H; or n=4, p is at least 1, X═H, Y═H; or n=2, 3 or 4, p is at least 1 and X═Y is selected from the group consisting of ClO₄, CF₃SO₃H, PF₆ and BF₄.
 18. A method for producing hydromorphone comprising converting morphine into hydromorphone in the presence of at least one catalyst, wherein the catalyst includes RhCl(P(C₆H₅)₃)₃or [Ru(P(C₆H₅)₃)₂Cl₂]₂. 